Concomitant Statins and the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Meta-Analysis

<div>Forest plots for the meta-analysis of the influence of concomitant statin on PFS of NSCLC patients receiving ICIs. (a) Forest plots for the overall meta-analysis; (b) subgroup analysis in univariate and multivariate studies.</div>

International Journal of Clinical Practice

fig2

Figure 2

Figure 2: Concomitant Statins and the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Meta-Analysis 

Figure 2 | Concomitant Statins and the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Meta-Analysis 